Genotype-guided Treatment in DLBCL

Clinical trial NCT05351346 · UNKNOWN

Trial details

NCT number: NCT05351346
Sponsor: Ruijin Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Diffuse Large B Cell Lymphoma

Start date: 2022-06-01
Primary completion: 2026-06-01
Enrollment: 1100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.